Sunny Balwani, the former President and COO of Theranos, has been sentenced to 10 years in prison for his role in a massive fraud scheme at the biotech company. Balwani was convicted in May of this year on two counts of wire fraud, along with Theranos’s founder and former CEO, Elizabeth Holmes.
Theranos was once a highly-touted biotech company that claimed to have developed a revolutionary blood-testing technology. However, an investigation by the Securities and Exchange Commission (SEC) and the U.S. Attorney’s Office for the Northern District of California revealed that the company’s technology was not as advanced as it claimed, and that it had misled investors and patients about the accuracy and reliability of its tests.
“The defendants perpetrated an elaborate, years-long fraud in which they exaggerated or made false statements about the company’s technology, business, and financial performance,” said U.S. Attorney David Anderson in a statement.
The investigation found that Balwani and Holmes had misled investors about the capabilities of Theranos’s technology, claiming it could perform hundreds of blood tests with just a few drops of blood, when in reality it could only perform a small number of tests and relied on traditional equipment for the majority of its testing. They also misled patients and doctors by providing inaccurate test results and covering up the problems with the technology.
“The defendants’ fraud was not a one-time mistake. It was an
elaborate, years-long fraud in which they lied to investors, partners, and the government,” said Jina L. Choi, Director of the SEC’s San Francisco Regional Office.
The sentencing of Balwani is the latest development in a case that has received widespread attention. In March of this year, Elizabeth Holmes, the former CEO of Theranos, was sentenced to 20 years in prison for her role in the fraud scheme.
“Balwani’s sentence serves as a reminder that those who cheat our markets will be held accountable, regardless of their position or status,” said U.S. SEC Chairman Gary Gensler.
The sentencing of Balwani and Holmes marks the end of a long legal battle that began in 2016 when Theranos was sued by investors and the SEC. The case serves as a warning to other companies and individuals who may be tempted to deceive investors and the public.
“The defendants’ fraud was not a one-time mistake. It was an elaborate, years-long fraud in which they lied to investors, partners, and the government,” said Jina L. Choi, Director of the SEC’s San Francisco Regional Office.
Overall, Sunny Balwani, the former President and COO of Theranos, has been sentenced to 10 years in prison for his role in a massive fraud scheme at the biotech company. Balwani was convicted of two counts of wire fraud, along with Theranos’s founder and former CEO, Elizabeth Holmes. The investigation revealed that the company’s technology was not as advanced as it claimed and had misled investors and patients about the accuracy and reliability of its tests. The sentencing of Balwani and Holmes marks the end of a long legal battle that began in 2016 and serves as a warning to other companies and individuals who may be tempted to deceive investors and the public.
